Canada: Canadian Rights Plan Reform: Will Shareholders Feel Better In The Morning After Swallowing This Pill?

Last Updated: March 15 2013
Article by Nicholas Dietrich, Tal Cyngiser and Kathleen M. Ritchie

Most Read Contributor in Canada, October 2018

On March 14, 2013, the Canadian Securities Administrators ("CSA") published for comment proposed National Instrument 62-105 Security Holder Rights Plans (the "Proposed Instrument") and its related Companion Policy. In a somewhat controversial move from the status quo, the CSA have proposed moving closer to Delaware's more director centric position on target board control over shareholder rights plans ("Rights Plans"), more commonly known as "poison pills". Current Canadian securities regulatory decisions pursuant to National Policy 62-202 Take-Over Bids – Defensive Tactics ("NP 62-202") have generally meant that challenges to poison pills by bidders have been largely successful, except in some cases where shareholders have approved poison pills in the face of a specific unsolicited or hostile bid. In these situations, shareholder approval of the poison pill has been viewed as a de facto rejection of the take-over bid by shareholders. While falling short of U.S. tolerance for poison pills which permit a target board to "just say no" to unsolicited or hostile bids (which reached a high water mark in the controversial Airgas decision1), the CSA's proposal could enable Canadian target boards to say "no for now" within shareholder approved limits. As with most matters dealing with enhanced defensive tactics, the devil is in the detail.

Purpose of the Proposed Instrument

According to the CSA, the purpose of the Proposed Instrument is to: (1) establish a comprehensive regulatory framework for Rights Plans in Canada that provides target boards and shareholders with greater discretion over the use of Rights Plans; (2) reduce the circumstances where regulatory intervention may be necessary; and (3) maintain an active market for corporate control. The following are some of the more significant provisions of the Proposed Instrument.

Shareholder Approval

Under the Proposed Instrument, ultimate control over the adoption, renewal, termination and modification of a Rights Plan is given to shareholders and not to target boards or securities regulators.

Adoption of a Rights Plan

Although effective upon adoption by a board of directors, a Rights Plan will be permitted to remain in place only if approved by shareholders within 90 days of the date it was adopted (or if adopted after a take-over bid has been made, within 90 days from the date the take-over bid was commenced). Aside from applying to a Rights Plan adopted at an annual shareholders' meeting, this also applies to the adoption of a second tactical Rights Plan with different or more restrictive terms than a Rights Plan previously approved at an annual shareholders' meeting. Where the requirement to obtain shareholder approval is not met within the specified time frame, the Rights Plan will terminate.

Renewal of a Rights Plan

A majority vote of shareholders is required to maintain the Rights Plan under the Proposed Instrument. Despite having obtained initial shareholder approval, a Rights Plan will become ineffective if the Rights Plan does not receive majority shareholder approval at each annual meeting held following the financial year in which the initial shareholder approval was obtained.

According to the CSA, the annual approval requirement is beneficial not only to shareholders, who are afforded an annual opportunity to re-evaluate the Rights Plan, but also to bidders who will now have an awareness as to when the Rights Plan will be put to a shareholder vote and can thereby time the commencement of a take-over bid accordingly.

Termination of a Rights Plan

Under the Proposed Instrument, shareholders are permitted to terminate a Rights Plan at any time through a majority vote. Leaving the ultimate decision as to whether to terminate a Rights Plan with the shareholders is, according to the CSA, preferable to a scenario where shareholders must consider whether to replace a majority of the board in order to terminate a Rights Plan. The CSA has also indicated that the ability of shareholders to vote on the specific question of termination of a Rights Plan affords a hostile bidder the chance to requisition shareholder support for the termination.

Modification of a Rights Plan

According to the CSA, material amendments to an existing Rights Plan are to be dealt with in the same manner as the adoption of a new Rights Plan. Consequently, under the Proposed Instrument, material amendments to a Rights Plan will be effective upon adoption by a board of directors, but must thereafter be approved by shareholders within 90 days.

Non-Approval or Termination of a Rights Plan

Under the Proposed Instrument, if a Rights Plan has become ineffective or has been terminated, the board of directors will be prohibited from adopting a new Rights Plan for a period of one year, unless a new Rights Plan is being adopted in the face of a take-over bid commenced after the prior Rights Plan was not approved or was terminated. Shareholder approval within 90 days of the date of adoption is still required.

The concern that shareholders may be left susceptible to a hostile take-over bid commenced during the one-year period is, according to the CSA, one reason why a general prohibition against adopting a new Rights Plan after a prior Rights Plan has become ineffective or was terminated is not being proposed.

Exclusion of Bidders

When a take-over bid has been commenced, shares held by a bidder will be excluded from the shareholder vote to adopt, maintain, amend or terminate a Rights Plan. The policy rationale behind the exclusion, according to the CSA, is the conflict of interest that bidders face when shareholders are voting on a Rights Plan.

Application of a Rights Plan

Under the Proposed Instrument, the application of a Rights Plan is restricted to a take-over bid or the acquisition of securities of the issuer. Other than as a result of these two circumstances, securities must not be distributed pursuant to a right issued under a Rights Plan, according to the CSA.

The Proposed Instrument also prohibits issuers from using a Rights Plan to treat bidders differently. According to the CSA, any waiver or modification to the application of a Rights Plan by an issuer in favour of one take-over bid must be granted with respect to all other take-over bids.

Regulatory Intervention

If the Proposed Instrument is adopted, the CSA expect that they would only intervene in the operation of a Rights Plan that is approved by shareholders in limited circumstances where the substance or spirit of the Proposed Instrument is not being complied with or there is a public interest rationale for the intervention not contemplated by the Proposed Instrument.

Comments on the Proposed Instrument

Comments on the Proposed Instrument are due June 12, 2013. The Proposed Instrument relates only to Rights Plans. That being said, the Proposed Instrument is part of a broader and continuing CSA initiative looking at defensive tactics, including private placements during take-over bids. CSA staff are continuing to consider whether changes should be made to NP 62-202 and the overall take-over bid regime.

The Right Balance?

It remains to be seen whether the Proposed Instrument will be amended after the comment period, but the new direction has been extensively deliberated by the CSA and appears to have momentum. It might be viewed as a typical Canadian approach to a tough policy issue, informed by the American situation, and yet striking a workable balance between shareholder rights and directors' defensive tactics.

The Related Consultation Paper from the Autorité des marchés financiers

In conjunction with the publication of the Proposed Instrument by the CSA, the Autorité des marchés financiers (the "AMF") has published a consultation paper (the "Consultation Paper") that presents an alternative approach to that offered by the Proposed Instrument.

The AMF believes that current market realities and the existing legal and economic environment necessitate a review of, and update to, the regulatory framework concerning all defensive tactics, not only Rights Plans. According to the AMF, its proposal seeks to restore the regulatory balance between bidders and target boards.

The AMF is proposing to replace NP 62-202 with a new policy that would recognize the directors' fiduciary duty to the corporation in responding to an unsolicited take-over bid and would redefine regulatory intervention on the ground of public interest. According to the AMF, under its proposal, appropriate deference would be given to directors facing unsolicited take-over bids to implement defensive tactics and intervention by the regulators would only occur in limited circumstances where an abuse of shareholders' rights is evident or a negative impact to the efficiency of capital markets exists.

To give directors appropriate deference, the AMF would examine the context in which the take-over bid takes place, the process followed by the directors and the basis for their recommendation to shareholders. The AMF has indicated that when appropriate safeguard measures are effectively implemented and monitored by boards and their independent advisors, this should provide reasonable assurance that directors' decisions are not tainted by conflicts of interest.

The AMF is also proposing that all bids be subject to a minimum 50% tender condition, and that all bids be extended for 10 days after the announcement that this tender condition has been met.

According to the AMF, the intent of the Consultation Paper is to provide a forum for discussion of these issues and to seek comment on the AMF proposal.

Footnotes

1. Air Products & Chemicals, Inc. v. Airgas, Inc., C.A. No. 5249-CC (Del. Ch. Feb. 15, 2011).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Blake, Cassels & Graydon LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Blake, Cassels & Graydon LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions